Chemical Name:Sacubitrol calcium saltCAS No.: 1369773-39-6Assay: ≥99%Appearance:White to off-white c
Correo electrónico: info@standard-groups.com
Sacubitrol calcium saltUsage： Used as pharmaceutical intermediate Sacubitrol calcium saltPackaging and Shipping： 25kg/ drum or as per buyer requirement. Sacubitrol calcium saltStorage: Ventilated and dry; separate from alkalis, oxidisers, organic materials and flammable materials
| Nombre | AHU-377 hemicalcium salt |
| Sinónimos | (alphar AHU-377 hemicalcium salt AHU-377 (heMicalciuM salt) LCZ696(valsartan + sacubitril) impurity 1 Ethyl (αR,γS)-γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-[1,1'-biphenyl]-4-pentanoate hemicalcium salt Calciumbis(4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl] amino} -4-oxobutanoate) |
| CAS | 1369773-39-6 |
| Fórmula Molecular | C48H56CaN2O10 |
| Masa Molar | 861.04364 |
| Punto de fusión | >140°C (dec.) |
| Solubilidad | DMSO (Slightly, Heated), Methanol (Slightly) |
| Apariencia | powder |
| color | white to beige |
| Condición de almacenamiento | -20°C |
| Estudio in vitro | Sacubitril (AHU-377) is a single molecule that is comprised of molecular moieties of valsartan, an ARB, and Sacubitril hemicalcium salt, a neprilysin inhibitor (1:1 ratio). Sacubitril (AHU-377) is converted by enzymatic cleavage of the ethyl ester into the active neprilysin inhibiting metabolite LBQ657. The inactive NEPi precursor, Sacubitril hemicalcium salt, does not inhibit collagen accumulation in fibroblasts nor cardiac myocyte hypertrophy. In cardiac fibroblasts, the active NEPi LBQ657 had no discernible effects. In contrast, LBQ657 modestly inhibits cardiac myocyte hypertrophy. |
| Estudio in vivo | In humans, Sacubitril (AHU-377)(t max 0.5-1.1 h) are absorbed quickly. Sacubitril hemicalcium salt is converted rapidly into LBQ657 with its t max being reached in 1.9-3.5 h. Mean t 1/2 values for the biologically active LBQ657 is 9.9-11.1 h.In vehicle-treated dogs, ANF increases urinary sodium excretion from 17.3±3.6 to 199.5±18.4 pequivkglmin. This effect is potentiated significantly in animals which receive Sacubitril (AHU-377). Urinary volume is also potentiated in animals which receive an iv administration of Sacubitril (AHU-377). |
Descargo de responsabilidad: El contenido anterior es para referencia y comunicación solo entre expertos de la industria, y no garantiza su exactitud o integridad. De acuerdo con las leyes y reglamentos relevantes y los reglamentos de este sitio web, las unidades o individuos que compren artículos relacionados deben obtener cualificaciones y condiciones de cualificación válidas.
Teléfono de la empresa
+86-21-6420 0566
Horas de trabajo
De lunes a viernes
Teléfono móvil:
13816217984
Correo electrónico:
info@qinsun-lab.com
